Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects

Journal of Cardiovascular Electrophysiology

Volumn 26, Issue 10, 2015, Pages 1111-1116

  Kolek, Matthew J ^a   Patel, Neel J ^a   Clair, Walter K ^a   Whalen, S Patrick ^b   Rottman, Jeffrey N ^a   Kanagasundram, Arvindh ^a   Shen, Sharon T ^a   Saavedra, Pablo J ^a   Estrada, Juan C ^a   Abraham, Robert L ^a   Ellis, Christopher R ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

antibacterial envelope; cardiac implantable electronic device; infection

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; DELAYED RELEASE FORMULATION; DRUG IMPLANT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BIOABSORBABLE ANTIBACTERIAL ENVELOPE; BIODEGRADABLE IMPLANT; BLOOD CULTURE; CARDIAC IMPLANT; CARDIAC IMPLANTABLE ELECTRONIC DEVICE; COHORT ANALYSIS; CONTROLLED STUDY; DEVICE INFECTION; DEVICE SAFETY; ENTEROCOCCUS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS; RISK ASSESSMENT; STREPTOCOCCUS; ADMINISTRATION AND DOSAGE; AGED; ARTIFICIAL HEART PACEMAKER; CAUSALITY; DELAYED RELEASE FORMULATION; DRUG IMPLANT; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TENNESSEE; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; AGED; ANTI-BACTERIAL AGENTS; CAUSALITY; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; DELAYED-ACTION PREPARATIONS; DRUG IMPLANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PREVALENCE; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; TENNESSEE; TREATMENT OUTCOME;

EID: 84945193553     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12768     Document Type: Article

References (23)

1. Voigt A, Shalaby A, Saba S,: Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006; 48: 586-597.
2. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, Pavri BB, Kurtz SM,: 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol 2011; 58: 1001-1006.
3. de Bie MK, van Rees JB, Thijssen J, Borleffs CJW, Trines SA, Cannegieter SC, Schalij MJ, van Erven L,: Cardiac device infections are associated with a significant mortality risk. Heart Rhythm 2012; 9: 494-498.
4. Sohail MR, Hussain S, Le KY, Dib C, Lohse CM, Friedman PA, Hayes DL, Uslan DZ, Wilson WR, Steckelberg JM, Baddour LM,: Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol 2011; 31: 171-183.
5. Da Costa A, Lelievre H, Kirkorian G, Celard M, Chevalier P, Vandenesch F, Etienne J, Touboul P,: Role of the preaxillary flora in pacemaker infections: A prospective study. Circulation 1998; 97: 1791-1795.
6. Kolek MJ, Dresen WF, Wells QS, Ellis CR,: Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients. Pacing Clin Electrophysiol 2012; 36: 354-361.
7. Bloom HL, Constantin L, Dan D, De Lurgio DB, El-Chami M, Ganz LI, Gleed KJ, Hackett FK, Kanuru NK, Lerner DJ, Rasekh A, Simons GR, Sogade FO, Sohail MR,; Cooperative Multicenter study Monitoring a CIED ANtimicrobial Device Investigators: Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol 2011; 34: 133-142.
8. Mittal S, Shaw RE, Michel K, Palekar R, Arshad A, Musat D, Preminger M, Sichrovsky T, Steinberg JS,: Cardiac implantable electronic device infections: Incidence, risk factors, and the effect of the AigisRx antibacterial envelope. Heart Rhythm 2014; 11: 595-601.
9. Shariff N, Eby E, Adelstein E, Jain S, Shalaby A, Saba S, Wang NC, Schwartzman D,: Health and economic outcomes associated with use of an antimicrobial envelope as a standard of care for cardiac implantable electronic device implantation. J Cardiovasc Electrophysiol 2015; 26: 783-789.
10. Roden D, Pulley J, Basford M, Bernard G, Clayton E, Balser J, Masys D,: Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther 2008; 84: 362-369.
11. Denny JC, Ritchie MD, Crawford DC, Schildcrout JS, Ramirez AH, Pulley JM, Basford MA, Masys DR, Haines JL, Roden DM,: Identification of genomic predictors of atrioventricular conduction: Using electronic medical records as a tool for genome science. Circulation 2010; 122: 2016-2021.
12. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG,: Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-381.
13. Courvoisier DS, Combescure C, Agoritsas T, Gayet-Ageron A, Perneger TV,: Performance of logistic regression modeling: Beyond the number of events per variable, the role of data structure. J Clin Epidemiol 2011; 64: 993-1000.
14. Joffe MM, Rosenbaum PR,: Invited commentary: propensity scores. Am J Epidemiol 1999; 150: 327-333.
15. Gum PA, Thamilarasan M, Watanabe J, Blackstone EH, Lauer MS,: Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease. JAMA 2001; 286: 1187-1194.
16. de Oliveira JC, Martinelli M, Nishioka SA, Varejão T, Uipe D, Pedrosa AA, Costa R, Danik SB,: Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators. Circ Arrhythm Electrophysiol 2009; 2: 29-34.
17. Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM, Miller HJ, Awad SS, Crosby CT, Mosier MC, AlSharif A, Berger DH,: Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010; 362: 18-26.
18. Kolek MJ, Ellis CR,: New approaches to decrease cardiac implantable electronic device infections. Cardiac Electrophysiology Clinics 2014; 6: 279-284.
19. Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ,: Comparison of mortality in women versus men with infections involving cardiovascular implantable electronic device. Am J Cardiol 2013; 112: 1403-1409.
20. Lekkerkerker JC, van Nieuwkoop C, Trines SA, van der Bom JG, Bernards A, van de Velde ET, Bootsma M, Zeppenfeld K, Jukema JW, Borleffs J-W, Schalij MJ, van Erven L,: Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 2009; 95: 715-720.
21. Dasgupta A, Montalvo J, Medendorp S, Lloyd-Jones DM, Ghossein C, Goldberger J, Passman R,: Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 2007; 49: 656-663.
22. Gould PA, Krahn AD,; Canadian Heart Rhythm Society Working Group on Device Advisories: Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA 2006; 295: 1907-1911.
23. Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J, Langberg J,: Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006; 29: 142-145.